Skip NavigationSkip to Content

Society of Toxicologic Pathology Digital Pathology and Image Analysis Special Interest Group Article*: Opinion on the Application of Artificial Intelligence and Machine Learning to Digital Toxicologic Pathology

  1. Author:
    Turner, Oliver C [ORCID]
    Aeffner, Famke
    Bangari, Dinesh S
    High, Wanda
    Knight, Brian
    Forest, Tom
    Cossic, Brieuc
    Himmel, Lauren E
    Rudmann, Daniel G [ORCID]
    Bawa, Bhupinder
    Muthuswamy, Anantharaman
    Aina, Olulanu H
    Edmondson,Elijah [ORCID]
    Saravanan, Chandrassegar
    Brown, Danielle L [ORCID]
    Sing, Tobias
    Sebastian, Manu M
  2. Author Address

    Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, East Hanover, NJ, USA., Amgen Inc, Research, Comparative Biology and Safety Sciences, San Francisco, CA, USA., Sanofi, Global Discovery Pathology, Framingham, MA, USA., High Preclinical Pathology Consulting, Rochester, NY, USA., Boehringer Ingelheim Pharmaceuticals Incorporated, Nonclinical Drug Safety, Ridgefield, CT, USA., Merck & Co, Inc, West Point, PA, USA., Roche, Pharmaceutical Research and Early Development (pRED), Roche Innovation Center, Basel, Switzerland., Division of Animal Care, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Charles River Laboratories, Pathology, Ashland, OH, USA., AbbVie, Preclinical Safety, North Chicago, IL, USA., Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA., Pathology/Histotechnology Laboratory, Frederick National Laboratory for Cancer Research, NIH, Frederick, MD, USA., Novartis, Novartis Institutes for Biomedical Research, Preclinical Safety, Cambridge, MA, USA., Charles River Laboratories, Durham, NC, USA., Novartis, Novartis Institutes for Biomedical Research, NIBR Informatics, Basel, Switzerland., Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, TX, USA.,
    1. Year: 2019
    2. Date: Oct 23
    3. Epub Date: 2019 10 23
  1. Journal: Toxicologic pathology
    1. Pages: 192623319881401
  2. Type of Article: Article
  3. Article Number: 192623319881401
  4. ISSN: 0192-6233
  1. Abstract:

    Toxicologic pathology is transitioning from analog to digital methods. This transition seems inevitable due to a host of ongoing social and medical technological forces. Of these, artificial intelligence (AI) and in particular machine learning (ML) are globally disruptive, rapidly growing sectors of technology whose impact on the long-established field of histopathology is quickly being realized. The development of increasing numbers of algorithms, peering ever deeper into the histopathological space, has demonstrated to the scientific community that AI pathology platforms are now poised to truly impact the future of precision and personalized medicine. However, as with all great technological advances, there are implementation and adoption challenges. This review aims to define common and relevant AI and ML terminology, describe data generation and interpretation, outline current and potential future business cases, discuss validation and regulatory hurdles, and most importantly, propose how overcoming the challenges of this burgeoning technology may shape toxicologic pathology for years to come, enabling pathologists to contribute even more effectively to answering scientific questions and solving global health issues. *This article is a product of a Special Interest Group of the Society of Toxicologic Pathology (STP). The views expressed in this article are those of the authors and do not necessarily represent the policies, positions, or opinions of the STP.

    See More

External Sources

  1. DOI: 10.1177/0192623319881401
  2. PMID: 31645203
  3. WOS: 000492130700001

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel